Crystal structure of unactivated c-KIT in complex with compound

Crystal structure of unactivated c-KIT in complex with compound — Image 2 of 18

Crystal structure of unactivated c-KIT in complex with compound — Image 3 of 18

Crystal structure of unactivated c-KIT in complex with compound — Image 4 of 18

Crystal structure of unactivated c-KIT in complex with compound — Image 5 of 18

Crystal structure of unactivated c-KIT in complex with compound — Image 6 of 18

Crystal structure of unactivated c-KIT in complex with compound — Image 7 of 18

Crystal structure of unactivated c-KIT in complex with compound — Image 8 of 18

Crystal structure of unactivated c-KIT in complex with compound — Image 9 of 18

Crystal structure of unactivated c-KIT in complex with compound — Image 10 of 18

Crystal structure of unactivated c-KIT in complex with compound — Image 11 of 18

Crystal structure of unactivated c-KIT in complex with compound — Image 12 of 18

Crystal structure of unactivated c-KIT in complex with compound — Image 13 of 18

Crystal structure of unactivated c-KIT in complex with compound — Image 14 of 18

Crystal structure of unactivated c-KIT in complex with compound — Image 15 of 18

Crystal structure of unactivated c-KIT in complex with compound — Image 16 of 18

Crystal structure of unactivated c-KIT in complex with compound — Image 17 of 18

Crystal structure of unactivated c-KIT in complex with compound — Image 18 of 18

3D model · NIH 3D

Crystal structure of unactivated c-KIT in complex with compound

Platform: NIH 3D
Price: Free
License: CC-BY; Print, modify and use commercially — credit the author.
Formats: X3DWRLSTLGLB

78 Downloads
49 Views

Author:cass condray

Published 2025-06-22

Description

PDB Classification: ONCOPROTEIN

Tags

oncoprotein hkl-2000 spodoptera frugiperda pdb_extract 3.24 phenix dev_2621

Comments 0

Loading comments…

More like this

Similar models

Structure of c-Kit with allosteric inhibitor 3G8

Structure of c-Kit with allosteric inhibitor 3G8

NIH 3D cass condray

Crystal structure of human C5a receptor in complex with an orthosteric antagonist PMX53 and an allosteric antagonist NDT9513727

Crystal structure of human C5a receptor in complex with an orthosteric antagonist PMX53 and an allosteric antagonist NDT9513727

NIH 3D Jianbin Zheng

Crystal structure of human C5a receptor in complex with an orthosteric antagonist PMX53 and an allosteric antagonist avacopan

Crystal structure of human C5a receptor in complex with an orthosteric antagonist PMX53 and an allosteric antagonist avacopan

NIH 3D Jianbin Zheng

HIV-1 protease (D25N, inactive) in complex with phage display optimized substrate SGIFLETS

HIV-1 protease (D25N, inactive) in complex with phage display optimized substrate SGIFLETS

NIH 3D cass condray

Crystal Structure of Human DHFR complexed with NADP and N10-formyl-tetrahydrofolate

Crystal Structure of Human DHFR complexed with NADP and N10-formyl-tetrahydrofolate

NIH 3D tcanglin

Crystal structure analysis of c4763, a uropathogenic E. coli-specific protein

Crystal structure analysis of c4763, a uropathogenic E. coli-specific protein

NIH 3D cass condray

Crystal structure of complex of BBKI and Bovine Trypsin

Crystal structure of complex of BBKI and Bovine Trypsin

Crystal Structure Human Immunodeficiency Virus-1 Matrix protein Mutant Q63R Crystal Form 1

Crystal Structure Human Immunodeficiency Virus-1 Matrix protein Mutant Q63R Crystal Form 1

NIH 3D cass condray

Crystal Structure of a receptor in Complex with inverse agonist

Crystal Structure of a receptor in Complex with inverse agonist

NIH 3D cass condray

Crystal Structure of Ca2+/CaM:Kv7.4 (KCNQ4) B helix complex

Crystal Structure of Ca2+/CaM:Kv7.4 (KCNQ4) B helix complex

NIH 3D cass condray

The structure of the C-terminal domains (C123) of Streptococcus intermedius antigen I/II (Pas)

The structure of the C-terminal domains (C123) of Streptococcus intermedius antigen I/II (Pas)

Crystal structure of human protease-activated receptor 1 (PAR1) bound with antagonist vorapaxar at 2.2 angstrom

Crystal structure of human protease-activated receptor 1 (PAR1) bound with antagonist vorapaxar at 2.2 angstrom

NIH 3D caklemens

Names are used only to indicate the source of a result. Polyzon is not affiliated with the listed sites.